University of South Florida H. Lee Moffitt Cancer Center & Research Inst.
Welcome,         Profile    Billing    Logout  
 7 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jain, Rohit
KEYNOTE-D78, NCT04879329: A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Recruiting
2
332
Europe, Canada, Japan, US, RoW
disitamab vedotin, RC48-ADC, pembrolizumab, KEYTRUDA®
Seagen Inc., Merck Sharp & Dohme LLC
Urothelial Carcinoma
11/26
05/28
CA209-63Y, NCT04863885: Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients

Checkmark Data from trial in combination with Ipilimumab and Nivolumab for Urothelial Carcinoma at ESMO 2021
Jul 2021 - Jul 2021: Data from trial in combination with Ipilimumab and Nivolumab for Urothelial Carcinoma at ESMO 2021
Active, not recruiting
1/2
46
US
Ipilimumab, Yervoy, Nivolumab, Opdivo, Sacituzumab govitecan, Trodelvy
H. Lee Moffitt Cancer Center and Research Institute, Bristol-Myers Squibb, Gilead Sciences
Metastatic Urothelial Carcinoma
04/26
04/27
NCT03837821: (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer

Active, not recruiting
1
20
US
Abemaciclib
Weill Medical College of Cornell University, Eli Lilly and Company
Bladder Cancer
07/24
12/25
MCC-20575, NCT04610671: Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC

Active, not recruiting
1
21
US
CG0070, Nivolumab
H. Lee Moffitt Cancer Center and Research Institute, CG Oncology, Inc., Richard M. Shulze Family Foundation
Muscle-Invasive Bladder Carcinoma, Bladder Cancer
01/25
01/26
NCT05375383: Microbial Colonization of Oral Probiotics

Recruiting
N/A
60
RoW
Streptococcus salivarius K12 lozenge, Probiotic S. salivarius K12 lozenges containing prebiotic A, Probiotic S. salivarius K12 lozenges containing prebiotic B, Probiotic S. salivarius K12 lozenges containing prebiotics A and B, Probiotic S. salivarius K12 powder, Probiotic S. salivarius K12 powder containing prebiotic A, Probiotic S. salivarius K12 powder containing prebiotic B, Probiotic S. salivarius K12 powder containing prebiotics A and B, Probiotic S. salivarius M18 lozenges, Probiotic S. salivarius M18 lozenges containing prebiotic A, Probiotic S. salivarius M18 lozenges containing prebiotic B, Probiotic S. salivarius M18 + lozenges containing prebiotic A and B
BLIS Technologies Limited
Microbial Colonization
08/22
09/22
NCT05750381: Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Balm in Healthy Adults.

Recruiting
N/A
20
RoW
Micrococcus luteus Blis Q24 balm, Placebo balm
BLIS Technologies Limited
Microbial Colonization
03/23
04/23

Download Options